Isotretinoin's impact on adult height debated. Research suggests that taking isotretinoin for acne during adolescence may not affect adult height, according to a study analyzing data from over 379,000 individuals in Denmark. More research is needed to confirm these findings.
SkinCareRadar tracks newly published skincare and dermatology research, then explains what the findings mean in plain language — with evidence labels, source links, and no hype.
Isotretinoin's impact on adult height debated. Research suggests that taking isotretinoin for acne during adolescence may not affect adult height, according to a study analyzing data from over 379,000 individuals in Denmark. More research is needed to confirm these findings.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.TretinoinAcnePublished: May 20, 2026
Isotretinoin Treatment in Adolescence May Not Affect Adult Height
Researchers studied whether taking isotretinoin for acne during adolescence affects adult height. They analyzed data from over 379,000 individuals in Denmark and found that isotretinoin use was not associated with reduced adult height. However, the study had limitations and more research is needed to confirm these findings.
Why it matters: This study may help inform decisions about isotretinoin treatment for acne in adolescents.
This study was a cross-sectional analysis of existing data and did not directly measure the effects of isotretinoin on growth. The sample size was large, but the study's design and limitations should be considered when interpreting the results.
Animal StudyResults in animals only. May or may not translate to humans.Published: May 20, 2026
New Hydrogel May Help Diabetic Wound Repair
Researchers created a hydrogel that uses near-infrared light to help repair diabetic wounds. This hydrogel has three effects: it kills bacteria, reduces inflammation, and promotes healing. In lab experiments and animal studies, it showed promise in treating diabetic wounds.
Why it matters: This research may help us better understand how to treat chronic wounds, which can be a major issue for people with diabetes.
This study was conducted in lab experiments and animal studies, so its effectiveness in humans is unknown. Further research is needed to confirm these findings.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.Skin Barrier DamagePublished: May 20, 2026
Understanding Infantile Atopic Dermatitis: New Research on Risk Factors
Researchers reviewed recent studies on infantile atopic dermatitis, a skin condition that affects babies. They found that prenatal probiotic use, breastmilk composition, and early antibiotic exposure may be linked to the condition. However, the exact causes are still unclear.
Why it matters: Understanding the risk factors for infantile atopic dermatitis may help parents and healthcare providers take preventive measures to reduce the condition's impact.
The review is based on existing studies, and more research is needed to confirm the findings and understand the complex interactions between genetic, environmental, and microbial factors.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Meta-AnalysisStatistical pooling of results from multiple studies.Published: May 19, 2026
Asivatrep May Help Improve Eczema Symptoms
Researchers studied the effectiveness and safety of a topical cream called asivatrep for treating atopic dermatitis (a type of eczema). They found that asivatrep may improve skin lesions and alleviate itching and sleep disturbances in patients with mild-to-moderate eczema. However, more research is needed to confirm these findings.
Why it matters: Understanding how asivatrep works may lead to new treatments for eczema and other skin conditions.
The study only included two small randomized controlled trials with 431 participants, and the results may not be generalizable to other populations or treatment settings.
Animal StudyResults in animals only. May or may not translate to humans.Published: May 19, 2026
Researchers found a compound that may help reduce skin scarring
A new compound called FR-1 was studied for its potential to reduce skin scarring. In lab experiments, it showed promise by reversing fibrosis and promoting regeneration. A small study in mice found that applying FR-1 to wounds reduced scar area.
Why it matters: This research may help improve our understanding of how to treat skin scarring and promote skin regeneration.
This study was conducted in mice and in lab experiments, and more research is needed to confirm its effectiveness in humans. The study's small sample size and limited scope also limit its findings.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.PeptidesSensitive SkinPublished: May 18, 2026
Topical calcineurin inhibitors may help restore skin barrier in atopic dermatitis
Researchers studied how topical calcineurin inhibitors affect the skin barrier in people with atopic dermatitis. They found that these treatments may improve skin hydration, reduce inflammation, and help restore the skin's natural barrier. However, more studies are needed to confirm these findings.
Why it matters: Understanding how topical calcineurin inhibitors affect the skin barrier could lead to better treatment options for people with atopic dermatitis.
This study focused on patients with atopic dermatitis, and more research is needed to confirm the long-term effects of topical calcineurin inhibitors on skin structure and the skin microbiome.
SkinCareRadar is a public research monitor focused on skincare ingredients, routines, devices, and skin conditions and concerns. It translates dermatology and cosmetic science research into plain language for the general public.
Every finding is linked to its original source. Evidence stages are labeled clearly. We do not diagnose, recommend treatment, or give medical advice. We distinguish cosmetic improvement from medically significant outcomes.